Pharmacodynamical Modeling of Two-Way Synergistic Effect for High-Throughput Drug Combination Screening in an Ex Vivo Reconstruction of Bone Marrow Using Primary Multiple Myeloma Cells
Conclusion: The proposed framework captures patient-specific combination effects using a pharmacodynamic model that can be used to screen for the most efficacious combination for a patient and across a cohort.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Sudalagunta, P. R., Renatino Canevarolo, R., Coelho Siqueira Silva, M. D., Meads, M. B., Tungesvik, A., De Avila, G., Shain, K. H., Siqueira Silva, A. Tags: 652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster I Source Type: research
More News: Bone Marrow Aspiration and Biopsy | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Dexamethasone | Myeloma | Study | Toxicology